Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949246 · ClinicalTrials.gov registry record
Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 221
- Enrollment target
NCT01949246: Completed study, sponsored by Massachusetts General Hospital.
NCT01949246 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 221 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949246 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 221 participants
- Enrollment target
Study Summary
The prospective study aims: 1. To determine the role and mechanism of biomarkers for prediction of response to CRT 2. To determine the role of biomarkers and their effect on left ventricular remodeling in patients undergoing CRT.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2007-09 |
| Est. Completion | 2016-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01949246
The ClinicalTrials.gov registry entry for NCT01949246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01949246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01949246 about?
NCT01949246 is a clinical study titled "Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)". The prospective study aims: 1. To determine the role and mechanism of biomarkers for prediction of response to CRT 2. To determine the role of biomarkers and their effect on left ventricular remodeling in patients undergoing CRT.
What is the current status of trial NCT01949246?
This trial is currently completed. The enrollment target is 221 participants. The study started on 2007-09. Estimated completion is 2016-01-01.
Who is sponsoring clinical trial NCT01949246?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.